Studies have shown that inhibition of glutamine metabolism leads to decreased intracellular GSH levels, which in turn reduces SERCA (sarcoendoplasmic reticulum calcium ATPase) activity, activating the calcium/NF-κB signaling pathway and ultimately upregulating PD-L1 expression in tumor cells [334]. Here, CD274 is linked to neoplasm.